Pfizer Ventures (us) Llc - Net Worth and Insider Trading

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in SpringWorks Therapeutics Inc (SWTX). Other recent insider transactions involving SpringWorks Therapeutics Inc (SWTX) include a net sale of 9,466 shares made by Julie Hambleton , a net sale of 98,000 shares made by Saqib Islam , and a net sale of 41,181 shares made by Daniel Pichl .

In summary, during the past 3 months, insiders sold 69,000 shares of SpringWorks Therapeutics Inc (SWTX) in total and bought 0 shares, with a net sale of 69,000 shares. During the past 18 months, 196,703 shares of SpringWorks Therapeutics Inc (SWTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,703 shares.

SpringWorks Therapeutics Inc (SWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 6,000 shares made by Sylvia Mcbrinn , a net purchase of 50,000 shares made by Short Jay M Phd , and a net purchase of 20,000 shares made by Lawrence Steinman .

In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 83,495 shares were bought by its insiders, resulting in a net purchase of 83,495 shares.

BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in Pyxis Oncology Inc (PYXS). Other recent insider transactions involving Pyxis Oncology Inc (PYXS) include a net purchase of 31,426 shares made by Pamela Ann Connealy , a net purchase of 10,000 shares made by Jitendra Wadhane , and a net sale of 36,558 shares made by Lara Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of Pyxis Oncology Inc (PYXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,558 shares of Pyxis Oncology Inc (PYXS) were sold and 41,426 shares were bought by its insiders, resulting in a net purchase of 4,868 shares.

Pyxis Oncology Inc (PYXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 240,342 shares made by Samuel Kintz , a net sale of 239,847 shares made by Joseph P Lyssikatos , and a net sale of 88,314 shares made by Benjamin Hohl .

In summary, during the past 3 months, insiders sold 183,359 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 183,359 shares. During the past 18 months, 4,855,709 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,855,709 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.